RecruitingPhase 2Phase 3NCT07310927

Alginate vs Sucralfate for GERD Symptomatic Relief

Alginate vs Sucralfate for GERD Symptomatic Relief in Combination With PPIS


Sponsor

CMH Lahore Medical College and Institute of Dentistry

Enrollment

140 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Gastroesophageal reflux disease (GERD) is a chronic gastrointestinal disorder characterized by the regurgitation of gastric contents into the esophagus.It can also present in an atypical manner such as chest pain, dental erosions, chronic cough, laryngitis, or asthma i.e. extra gastroesophageal symptoms. Sucralfate is a unique anti-ulcer drug and is a basic aluminum salt of sucrose octa-sulfate. It forms a protective layer, enhancing bicarbonate production, demonstrating anti-peptic properties, and fostering tissue growth, regeneration, and repair and it undergoes minimal enteral reabsorption. Alginate is a naturally occurring anionic polymer typically obtained from brown seaweed and has been extensively investigated and used for many biomedical applications, due to its biocompatibility, low toxicity, relatively low cost, and mild gelation by addition of divalent cations such as Ca2+.Both sucralfate and alginate have been in use for the treatment and symptomatic relief of GERD and are well tolerated oral formulations.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria1

  • All patients having symptoms of severe GERD for more than 3 times /week

Exclusion Criteria7

  • Patients with preexisting cardiovascular disorders
  • Patients with chronic kidney or liver diseases
  • Patients with gross abnormalities on upper GI endoscopies e.g.; ulcers, tumors or those with history of upper GI surgery
  • Pregnant and breast feeding
  • Absence of Erosive esophagitis
  • Patients with peptic esophageal ulcers
  • PPI use within 4 weeks

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAlginate

2 Table spoon spoon suspension syrup twice a day before meal.

DRUGSucralfate

2 Table spoon spoon suspension syrup twice a day before meal.


Locations(1)

Cmh Lahore

Lahore, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07310927


Related Trials